Counihan Muireann, Stein Isabella, Flynn Cecilia, O'Regan Aishling, Clarke Shane, Ledwidge Mark, Ryan Cristín
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.
Res Social Adm Pharm. 2025 May;21(5):287-320. doi: 10.1016/j.sapharm.2025.01.011. Epub 2025 Jan 27.
The scope of practice for community pharmacists across the United Kingdom (UK) and Ireland is expanding, with advanced pharmacy services (APS) that exceed the traditional scope of practice of a community pharmacist being provided. Current literature highlights that there is variation in APS provision and renumeration for those service across the UK and Ireland.
This scoping review aims to describe and compare the APS provided by community pharmacists across the UK and Ireland for which community pharmacists receive government reimbursement and explore stakeholder perspectives of these services.
This scoping review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist and followed Arskey and O'Malley's guidance for undertaking scoping reviews. Systematic searches of the electronic databases Embase, PubMed, SCOPUS and Google Scholar were undertaken using search terms such as 'community pharmacist' and 'advanced service', from January 2010 to August 2022. Articles were included if they reported an APS, renumeration for an APS and/or stakeholders' views of APS. Results were summarised narratively.
After screening 4009 records, 75 publications were included. More Government renumerated APS were provided across the UK [Wales (n = 14); England (n = 10); Scotland (n = 8); Northern Ireland (n = 4)] than in Ireland (n = 4). Stakeholders (patients, pharmacists and general practitioners) found the provision of APS in community pharmacy ideal especially when tailored to local demographic needs, noting accessibility and economic benefits as key advantages.
Despite similarities in the traditional services provided by community pharmacists, there is diversion in the provision and availability of APS across the UK and Ireland. Further APS could be provided in some countries which can reflect local population needs.
英国和爱尔兰社区药剂师的执业范围正在扩大，他们开始提供超出传统社区药剂师执业范围的高级药学服务（APS）。当前文献表明，英国和爱尔兰在这些服务的提供和报酬方面存在差异。
本综述旨在描述和比较英国和爱尔兰社区药剂师提供的、可获得政府报销的高级药学服务，并探讨利益相关者对这些服务的看法。
本综述按照系统评价和Meta分析扩展版的范围综述清单中的首选报告项目进行报告，并遵循Arskey和O'Malley进行范围综述的指导原则。使用“社区药剂师”和“高级服务”等搜索词，对Embase、PubMed、SCOPUS和谷歌学术等电子数据库进行了系统检索，检索时间为2010年1月至2022年8月。如果文章报告了高级药学服务、该服务的报酬和/或利益相关者对高级药学服务的看法，则纳入研究。结果采用叙述性总结。
在筛选了4009条记录后，纳入了75篇出版物。英国（威尔士（n = 14）；英格兰（n = 10）；苏格兰（n = 8）；北爱尔兰（n = 4））提供的由政府报销的高级药学服务比爱尔兰（n = 4）更多。利益相关者（患者、药剂师和全科医生）认为社区药房提供高级药学服务非常理想，特别是当服务针对当地人口需求进行定制时，并指出可及性和经济效益是关键优势。
尽管社区药剂师提供的传统服务存在相似之处，但英国和爱尔兰在高级药学服务的提供和可得性方面存在差异。一些国家可以进一步提供能反映当地人口需求的高级药学服务。
